These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38075432)

  • 21. Evaluation of dog vaccination schemes against rabies in Kinshasa, Democratic Republic of the Congo.
    Kazadi Kawaya E; Marcotty T; Mfumu-Kazadi LM; Marcotty D; Van Gucht S; Kirschvink N
    Prev Vet Med; 2022 Jan; 198():105531. PubMed ID: 34773832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral vaccination of dogs with recombinant rabies virus vaccines.
    Rupprecht CE; Hanlon CA; Blanton J; Manangan J; Morrill P; Murphy S; Niezgoda M; Orciari LA; Schumacher CL; Dietzschold B
    Virus Res; 2005 Jul; 111(1):101-5. PubMed ID: 15896409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral vaccination of wildlife against rabies: Differences among host species in vaccine uptake efficiency.
    Vos A; Freuling CM; Hundt B; Kaiser C; Nemitz S; Neubert A; Nolden T; Teifke JP; Te Kamp V; Ulrich R; Finke S; Müller T
    Vaccine; 2017 Jul; 35(32):3938-3944. PubMed ID: 28641888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The serological response of young dogs to the Flury LEP strain of rabies virus vaccine.
    Aghomo HO; Oduye OO; Rupprecht CE
    Vet Res Commun; 1990; 14(5):415-25. PubMed ID: 2247948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
    Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH
    Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new recombinant rabies virus expressing a green fluorescent protein: A novel and fast approach to quantify virus neutralizing antibodies.
    Qin S; Volokhov D; Rodionova E; Wirblich C; Schnell MJ; Chizhikov V; Dabrazhynetskaya A
    Biologicals; 2019 May; 59():56-61. PubMed ID: 30898479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody response of cattle to vaccination with commercial modified live rabies vaccines in Guatemala.
    Gilbert A; Greenberg L; Moran D; Alvarez D; Alvarado M; Garcia DL; Peruski L
    Prev Vet Med; 2015 Jan; 118(1):36-44. PubMed ID: 25466762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study.
    Li R; Li Y; Wen S; Wen H; Nong Y; Mo Z; Xie F; Pellegrini M
    Hum Vaccin Immunother; 2015; 11(2):435-42. PubMed ID: 25692350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults.
    Ma J; Wang H; Li J; Chang L; Xie Y; Liu Z; Zhao Y; Malerczyk C
    Hum Vaccin Immunother; 2014; 10(10):2805-12. PubMed ID: 25483635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Comparative Study of the RAPINA and the Virus-Neutralizing Test (RFFIT) for the Estimation of Antirabies-Neutralizing Antibody Levels in Dog Samples.
    Manalo DL; Yamada K; Watanabe I; Miranda MEG; Lapiz SMD; Tapdasan E; Petspophonsakul W; Inoue S; Khawplod P; Nishizono A
    Zoonoses Public Health; 2017 Aug; 64(5):355-362. PubMed ID: 27863040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thermotolerance of an inactivated rabies vaccine for dogs.
    Lankester FJ; Wouters PAWM; Czupryna A; Palmer GH; Mzimbiri I; Cleaveland S; Francis MJ; Sutton DJ; Sonnemans DGP
    Vaccine; 2016 Nov; 34(46):5504-5511. PubMed ID: 27729174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective immune response of oral rabies vaccine in stray dogs, corsacs and steppe wolves after a single immunization.
    Zhugunissov K; Bulatov Y; Taranov D; Yershebulov Z; Koshemetov Z; Abduraimov Y; Kondibayeva Z; Samoltyrova A; Amanova Z; Khairullin B; Sansyzbay A
    Arch Virol; 2017 Nov; 162(11):3363-3370. PubMed ID: 28766059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies.
    Zhang S; Liu Y; Fooks AR; Zhang F; Hu R
    Vaccine; 2008 Jan; 26(3):345-50. PubMed ID: 18083277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-visit, 4-site intradermal (ID) rabies vaccination induces robust immune responses 5 years after 1-week, 4-site ID primary post-exposure prophylaxis in the Philippines.
    Quiambao BP; Ambas C; Diego S; Bosch Castells V; Korejwo J; Petit C; Rasuli A; Houillon G
    Vaccine; 2020 May; 38(21):3740-3746. PubMed ID: 32280042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative evaluation of specific ELISA and RFFIT antibody assays in the assessment of dog immunity against rabies.
    Bahloul C; Taieb D; Kaabi B; Diouani MF; Ben Hadjahmed S; Chtourou Y; Imen B'Chir B; Dellagi K
    Epidemiol Infect; 2005 Aug; 133(4):749-57. PubMed ID: 16050522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Comparative Evaluation of the Estimation of Rabies Virus Antibodies among Free-Roaming, Vaccinated Dogs in Bengaluru, India.
    Das LJ; Isloor S; Santosh AK; Bhat A; Sharada R; Rathnamma D; Veeregowda BM; Phaniraj KL; Abhijit Kumar N; T Vanak A
    Viruses; 2022 Feb; 14(3):. PubMed ID: 35336891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of two serological methods for detecting the immune response after rabies vaccination in dogs and cats being exported to rabies-free areas.
    Briggs DJ; Smith JS; Mueller FL; Schwenke J; Davis RD; Gordon CR; Schweitzer K; Orciari LA; Yager PA; Rupprecht CE
    Biologicals; 1998 Dec; 26(4):347-55. PubMed ID: 10403038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Environmental distribution of certain modified live-virus vaccines with a high safety profile presents a low-risk, high-reward to control zoonotic diseases.
    Head JR; Vos A; Blanton J; Müller T; Chipman R; Pieracci EG; Cleaton J; Wallace R
    Sci Rep; 2019 May; 9(1):6783. PubMed ID: 31043646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An electrochemiluminescence assay for analysis of rabies virus glycoprotein content in rabies vaccines.
    Smith TG; Ellison JA; Ma X; Kuzmina N; Carson WC; Rupprecht CE
    Vaccine; 2013 Jul; 31(33):3333-8. PubMed ID: 23742991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Field trial with oral vaccination of dogs against rabies in the Philippines.
    Estrada R; Vos A; De Leon R; Mueller T
    BMC Infect Dis; 2001; 1():23. PubMed ID: 11737869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.